Present interferon-based therapy for chronic hepatitis C is limited by both efficacy and tolerability. Telaprevir and boceprevir are the first two direct-acting antiviral drugs (DAAs) that inhibit ...
Small Molecule Combination Therapies Are Being Investigated to Increase Response Rates Researchers agree that now is a crucial time to be involved in hepatitis C virus (HCV) research. “Current ...
Model showing how fatty acid metabolism triggers lipid peroxidation and regulates hepatitis C virus replication. Production of polyunsaturated fatty acids (PUFAs) is regulated predominantly by FADS2.
Occult HCV and HBV infections are recently identified entities whose existence became evident when nucleic acid amplification assays of enhanced sensitivity were employed for the detection of viral ...
Not Just an Epidemic of Painkillers: An Epidemic of Pain Chronic hepatitis C virus (HCV) infection increases the risk for several types of cancer, including hepatocellular carcinoma (HCC) and B-cell ...
Hepatitis C virus persists in the human body for decades and damages the liver by inducing chronic inflammation, ultimately leading to cirrhosis and liver cancer. A new study led by researchers at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results